196 related articles for article (PubMed ID: 18071006)
1. Associations between diabetes and clinical markers of benign prostatic hyperplasia among community-dwelling Black and White men.
Sarma AV; Burke JP; Jacobson DJ; McGree ME; St Sauver J; Girman CJ; Lieber MM; Herman W; Macoska J; Montie JE; Jacobsen SJ
Diabetes Care; 2008 Mar; 31(3):476-82. PubMed ID: 18071006
[TBL] [Abstract][Full Text] [Related]
2. Diabetes treatment and progression of benign prostatic hyperplasia in community-dwelling black and white men.
Sarma AV; St Sauver JL; Hollingsworth JM; Jacobson DJ; McGree ME; Dunn RL; Lieber MM; Jacobsen SJ;
Urology; 2012 Jan; 79(1):102-8. PubMed ID: 22112286
[TBL] [Abstract][Full Text] [Related]
3. Comparison of lower urinary tract symptom severity and associated bother between community-dwelling black and white men: the Olmsted County Study of Urinary Symptoms and Health Status and the Flint Men's Health Study.
Sarma AV; Wei JT; Jacobson DJ; Dunn RL; Roberts RO; Girman CJ; Lieber MM; Cooney KA; Schottenfeld D; Montie JE; Jacobsen SJ; ;
Urology; 2003 Jun; 61(6):1086-91. PubMed ID: 12809866
[TBL] [Abstract][Full Text] [Related]
4. The natural history of lower urinary tract symptoms in black American men: relationships with aging, prostate size, flow rate and bothersomeness.
Wei JT; Schottenfeld D; Cooper K; Taylor JM; Faerber GJ; Velarde MA; Bree R; Montie JE; Cooney KA
J Urol; 2001 May; 165(5):1521-5. PubMed ID: 11342910
[TBL] [Abstract][Full Text] [Related]
5. Association between socioeconomic status (SES) and lower urinary tract symptom (LUTS) severity among black and white men.
Fowke JH; Munro H; Signorello LB; Blot WJ; Penson DF;
J Gen Intern Med; 2011 Nov; 26(11):1305-10. PubMed ID: 21720905
[TBL] [Abstract][Full Text] [Related]
6. Risk factors for lower urinary tract symptoms in a population-based sample of African-American men.
Joseph MA; Harlow SD; Wei JT; Sarma AV; Dunn RL; Taylor JM; James SA; Cooney KA; Doerr KM; Montie JE; Schottenfeld D
Am J Epidemiol; 2003 May; 157(10):906-14. PubMed ID: 12746243
[TBL] [Abstract][Full Text] [Related]
7. Associations of lower urinary tract symptoms with prostate-specific antigen levels, and screen-detected localized and advanced prostate cancer: a case-control study nested within the UK population-based ProtecT (Prostate testing for cancer and Treatment) study.
Collin SM; Metcalfe C; Donovan J; Lane JA; Davis M; Neal D; Hamdy F; Martin RM
BJU Int; 2008 Nov; 102(10):1400-6. PubMed ID: 18540932
[TBL] [Abstract][Full Text] [Related]
8. Benign prostatic hyperplasia: racial differences in treatment patterns and prostate cancer prevalence.
Pettaway CA; Lamerato LE; Eaddy MT; Edwards JK; Hogue SL; Crane MM
BJU Int; 2011 Oct; 108(8):1302-8. PubMed ID: 21371244
[TBL] [Abstract][Full Text] [Related]
9. Associations between C-reactive protein and benign prostatic hyperplasia/lower urinary tract symptom outcomes in a population-based cohort.
St Sauver JL; Sarma AV; Jacobson DJ; McGree ME; Lieber MM; Girman CJ; Nehra A; Jacobsen SJ
Am J Epidemiol; 2009 Jun; 169(11):1281-90. PubMed ID: 19395697
[TBL] [Abstract][Full Text] [Related]
10. Distribution and associations of [-2]proenzyme-prostate specific antigen in community dwelling black and white men.
Rhodes T; Jacobson DJ; McGree ME; St Sauver JL; Sarma AV; Girman CJ; Lieber MM; Klee GG; Demissie K; Jacobsen SJ
J Urol; 2012 Jan; 187(1):92-6. PubMed ID: 22093189
[TBL] [Abstract][Full Text] [Related]
11. Potential selection bias in a community-based study of PSA levels in African-American men.
Heeringa SG; Alcser KH; Doerr K; Strawderman M; Cooney K; Medbery B; Schottenfeld D
J Clin Epidemiol; 2001 Feb; 54(2):142-8. PubMed ID: 11166529
[TBL] [Abstract][Full Text] [Related]
12. Age-stratified normal values for prostate volume, PSA, maximum urinary flow rate, IPSS, and other LUTS/BPH indicators in the German male community-dwelling population aged 50 years or older.
Berges R; Oelke M
World J Urol; 2011 Apr; 29(2):171-8. PubMed ID: 21221974
[TBL] [Abstract][Full Text] [Related]
13. Non-steroidal anti-inflammatory drug use and the risk of benign prostatic hyperplasia-related outcomes and nocturia in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial.
Sutcliffe S; Grubb Iii RL; Platz EA; Ragard LR; Riley TL; Kazin SS; Hayes RB; Hsing AW; Andriole GL;
BJU Int; 2012 Oct; 110(7):1050-9. PubMed ID: 22429766
[TBL] [Abstract][Full Text] [Related]
14. Benign prostate specific antigen distribution and associations with urological outcomes in community dwelling black and white men.
Rhodes T; Jacobson DJ; McGree ME; St Sauver JL; Sarma AV; Girman CJ; Lieber MM; Klee GG; Demissie K; Jacobsen SJ
J Urol; 2012 Jan; 187(1):87-91. PubMed ID: 22093190
[TBL] [Abstract][Full Text] [Related]
15. Hyperglycemia, hyperinsulinemia, insulin resistance, and the risk of BPH/LUTS severity and progression over time in community dwelling black men: the Flint Men's Health Study.
Wallner LP; Hollingsworth JM; Dunn RL; Kim C; Herman WH; Sarma AV;
Urology; 2013 Oct; 82(4):881-6. PubMed ID: 23915515
[TBL] [Abstract][Full Text] [Related]
16. The role of BPH, lower urinary tract symptoms, and PSA levels on erectile function of Brazilian men who undergo prostate cancer screening.
Antunes AA; Srougi M; Dall'oglio MF; Vicentini F; Paranhos M; Freire GC
J Sex Med; 2008 Jul; 5(7):1702-7. PubMed ID: 18194186
[TBL] [Abstract][Full Text] [Related]
17. Sexually transmitted infections, benign prostatic hyperplasia and lower urinary tract symptom-related outcomes: results from the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial.
Breyer BN; Huang WY; Rabkin CS; Alderete JF; Pakpahan R; Beason TS; Kenfield SA; Mabie J; Ragard L; Wolin KY; Grubb RL; Andriole GL; Sutcliffe S
BJU Int; 2016 Jan; 117(1):145-54. PubMed ID: 25601300
[TBL] [Abstract][Full Text] [Related]
18. Relationship between serum prostate-specific antigen and prostate volume in Korean men with benign prostatic hyperplasia: a multicentre study.
Chung BH; Hong SJ; Cho JS; Seong DH
BJU Int; 2006 Apr; 97(4):742-6. PubMed ID: 16536765
[TBL] [Abstract][Full Text] [Related]
19. Autonomic nervous system overactivity in men with lower urinary tract symptoms secondary to benign prostatic hyperplasia.
McVary KT; Rademaker A; Lloyd GL; Gann P
J Urol; 2005 Oct; 174(4 Pt 1):1327-433. PubMed ID: 16145413
[TBL] [Abstract][Full Text] [Related]
20. Racial differences in longitudinal changes in serum prostate-specific antigen levels: the Olmsted County Study and the Flint Men's Health Study.
Sarma AV; St Sauver JL; Jacobson DJ; McGree ME; Klee GG; Lieber MM; Girman CJ; Hollingsworth JM; Jacobsen SJ;
Urology; 2014 Jan; 83(1):88-93. PubMed ID: 24139354
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
